Glaxosmithkline Consumer Healthcare Ltd(merged) Share Holding Pattern
₹ 2.7 Cr
Volume Transacted
(Apr 15, 2020)
2.5 K
Stocks Traded
(Apr 15, 2020)
Last Updated on: Nov 22, 2024
×
PRICE
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
Market Price of GlaxoSmithkline Consumer Healthcare Ltd(Merged)
1M
1Y
3Y
5Y
Monitoring GlaxoSmithkline Consumer Healthcare Ltd(Merged) share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
Last Ten Days Market Price
| Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
|---|
| 15 Apr 2020 | 10753.65 | 10500 | 10845.75 | 10394.05 |
| 13 Apr 2020 | 10232.35 | 10700 | 10700 | 10123.85 |
| 09 Apr 2020 | 10365.65 | 10757.7 | 10757.7 | 10152.25 |
| 08 Apr 2020 | 10615.25 | 11109.85 | 11290 | 10500 |
| 07 Apr 2020 | 10590.7 | 9769 | 10666.15 | 9769 |
| 03 Apr 2020 | 9367.15 | 9549 | 9748.35 | 9284 |
| 01 Apr 2020 | 9548.3 | 9993.1 | 10075 | 9435.2 |
| 31 Mar 2020 | 9993.1 | 9596.65 | 10015 | 9522.05 |
| 30 Mar 2020 | 9452.1 | 9250 | 9517.5 | 9203.1 |
| 27 Mar 2020 | 9413.55 | 9759.5 | 9818.85 | 9220 |
| Date |  Price (₹) |
|---|---|
| 15 Apr 2020 | 10753.65 |
| 13 Apr 2020 | 10232.35 |
| 09 Apr 2020 | 10365.65 |
| 08 Apr 2020 | 10615.25 |
| 07 Apr 2020 | 10590.7 |
| 03 Apr 2020 | 9367.15 |
| 01 Apr 2020 | 9548.3 |
| 31 Mar 2020 | 9993.1 |
| 30 Mar 2020 | 9452.1 |
| 27 Mar 2020 | 9413.55 |
Document
Annual Reports
N/A
Credit Ratings
N/A
Concalls
Data not available
Data not available
FAQs for EPS of GlaxoSmithkline Consumer Healthcare Ltd(Merged)
On what factors does the shareholding pattern of GlaxoSmithkline Consumer Healthcare Ltd(Merged) change frequently?
The shareholding pattern of GlaxoSmithkline Consumer Healthcare Ltd(Merged) can change due to various factors such as stock market transactions, new share issuances, buy-backs, or changes in ownership by institutional and retail investors.
How often is GlaxoSmithkline Consumer Healthcare Ltd(Merged)'s shareholding pattern updated?
The GlaxoSmithkline Consumer Healthcare Ltd(Merged) shareholding pattern is typically updated quarterly or semi-annually, depending on regulatory requirements and internal reporting schedules.
What categories are included in the shareholding pattern of GlaxoSmithkline Consumer Healthcare Ltd(Merged)?
Categories included in the shareholding pattern of GlaxoSmithkline Consumer Healthcare Ltd(Merged) include promoter/management holdings, institutional investors, retail investors, and others such as foreign investors.
Why is the shareholding pattern of GlaxoSmithkline Consumer Healthcare Ltd(Merged) important for investors?
The shareholding pattern of GlaxoSmithkline Consumer Healthcare Ltd(Merged) is important for investors as it provides insights into ownership distribution, control dynamics, and the potential influence of major shareholders on company decisions and stock performance.
Where can I find the latest shareholding pattern of GlaxoSmithkline Consumer Healthcare Ltd(Merged)?
The latest shareholding pattern of GlaxoSmithkline Consumer Healthcare Ltd(Merged) can be found on BlinkX. You may also check the quarterly financial reports, which are available on the company’s official website under the Investor Relations section. Additionally, you can check stock exchange websites like NSE and BSE for the most recent filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Unlimited trading at just
Rs. 199*